medicare part d
I needed an antidote. Too many drug ads—smiling people glowing with the pleasure of their successful medical treatments. But of course, they are actors.
Open enrollment for your prescription drug plan under Medicare Part D ends today. Over 1,800 private insurance plans to choose from, but they all cost too much, and the costs keep climbing.
I finally saw “Sicko” with a friend the other night. About half way through the movie, after we hear the heart breaking tales of a few Americans’ health care disaster stories, Michael Moore asks the question, “Who are we?”..a question that stays in your mind long after the closing credits. But a more appropriate question might be: How do we fix this?
I may have discovered an unknown side effect of those prescription drug TV ads—lowering my IQ. As I digested new diseases, wondering if I have them, and new cures, wondering if I should ask for them, the drug companies apparently walked away with all the money.
Over 60% of campaign contributions from the drug industry went to Republicans last year.
In 2006, drug companies spent over $4 billion on drug ads. However, this year, Congress may look to limit direct-to-consumer ads.
The US House of Representatives yesterday voted 255-170 in favor of requiring the HHS secretary to negotiate drug prices with drug manufacturers for Medicare Part D plans…
The New York Times and Washington Post reported on the pharmaceutical industry’s fears of a Democratic-controlled Congress. Those fears were best captured in a secret internal memo from drug maker GlaxoSmithKline.
A November 19th article titled, “Big Pharma on a mission to woo Democrats” from London’s Financial Times reported that the industry may now have to work overtime to get in the Dems’ good graces.
Drug companies have made huge profits off the Medicare prescription drug program, or Part D. You can expect Pfizer and others to have huge holiday parties this year…they’ll be breaking out the champagne while some seniors can expect a “donut hole” in their stockings.